Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Sledge on Genomic Sequencing in Patients With Breast Cancer

George Sledge, Jr., MD
Published: Sunday, Oct 14, 2018



George Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, discusses the benefit to the cost of genomic sequencing decreasing overtime.

With this cost continuously dropping, for the first time oncologists are able to do comprehensive looks at mutations in human patients with cancer. By doing so, they can do a better job at tailoring therapy for those patients.


George Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, discusses the benefit to the cost of genomic sequencing decreasing overtime.

With this cost continuously dropping, for the first time oncologists are able to do comprehensive looks at mutations in human patients with cancer. By doing so, they can do a better job at tailoring therapy for those patients.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Miami Breast Cancer Conference®: Attendee Tumor Board OnlineNov 30, 20181.5
Community Practice Connections™: 1st Annual Paris Breast Cancer Conference™Dec 31, 20181.5
Publication Bottom Border
Border Publication
x